glp-1 87 kg journey Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Optimizing GLP-1 therapies for obesity

Over time, researchers have discovered they can also lead to significant weight loss and improvements in a variety of obesity-related conditions

The risks include: Infection at the surgical site, which can lead to life-threatening sepsis Slowed or delayed healing Anesthesia risks Hernia formation (in open abdominal surgery) Increased risk of blood clots Mobility concerns Increased damage to the heart and/or kidneys (for older patients, or those with pre-existing conditions) Can I file a lawsuit if I suffered injury while taking Ozempic or Mounjaro

Consistent access to therapy is also essential, as interruptions due to financial or logistical barriers can exacerbate GI symptoms

J Clin Endocrinol Metab 2019;104:2463-72.ArticlePubMed 43

So in principle, you can use pretty low doses of these hormones to elicit the effect, and they are not likely to elicit immediate, at least, toxic effects in the body